ARWR
Arrowhead Pharmaceuticals, Inc.
NASDAQ · USHealthcareBiotechnology
$71.65-3.57%
Price as of Jul 20, 2026
ARWR profitability
Arrowhead Pharmaceuticals, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 100.0%
- EBITDA margin
- -21.6%
- EBIT margin
- -35.7%
- Net margin
- -48.4%
- Free cash flow margin
- -8.2%
Returns
- Return on equity
- -49.0%
- Return on assets
- -13.3%
- Return on invested capital
- -11.2%
- Asset turnover
- 0.32x
Cash efficiency
- Cash from operations
- -$36.3M
- Cash per share
- $13
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.